LONDON, Dec 16 (Reuters) - The U.S. health regulator has approved GSK's add-on drug to treat severe asthma, the drugmaker ...

In this video, Jonathan A. Bernstein, MD, discusses his American College of Allergy, Asthma & Immunology Annual Scientific ...

In this video, Jonathan A. Bernstein, MD, discusses an American College of Allergy, Asthma & Immunology Annual Scientific ...

The MHRA has approved depemokimab as an add on treatment for severe asthma and chronic rhinosinusitis with nasal polyps.

Allied Market Research published a report, titled, 'Respiratory Inhaler Devices Market by Product (Metered Dose Inhalers, Dry ...

December 16 is National Chocolate-Covered Anything Day, which is either a celebration of culinary creativity or an excuse to ...

Drugmaker GSK said on Tuesday that Exdensur (depemokimab), an ultra-long-acting biologic to treat respiratory diseases, has ...

Health experts are hailing a major medical breakthrough after the US Food and Drug Administration approved two new ...

Cooper is a 1-year-old Shepherd/mix who is funny, gentle, affectionate and entertaining. Arriving at CAPS as a stray, he has ...

Exploration of key clinical trial data and real-world evidence on dupilumab in asthma and COPD presented at the ERS and CHEST ...

Noida: With the air quality index (AQI) in the toxic levels for weeks and not a single clean-air day recorded this season, ...

Delhi is once again facing a severe air pollution emergency, with a thick layer of smog making it almost impossible to be ...